IMA vs STE
ImageneBio, Inc. (IMA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
IMA currently screens at market cap $64.7M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the IMA and STE stock pages for the full models.
Not investment advice.